InMed Pharmaceuticals Inc. (INM) vs Longeveron Inc. (LGVN)
A side-by-side comparison of InMed Pharmaceuticals Inc. and Longeveron Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INM
InMed Pharmaceuticals Inc.
$1.33HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
LGVN
Longeveron Inc.
$2.39HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — INM vs LGVN
growth of $100 · dividends reinvested · last 6yINM -99.9% (-71.5%/yr)LGVN -99.7% (-61.2%/yr)LGVN compounded faster over this window
Log scale — wide-divergence pair
INM LGVN
INM vs LGVN: by the numbers
- •INM is the larger company ($7M vs $7M market cap).
- •Both run net losses; INM's is the smaller (-0.61% vs -1977.59% net margin).
Metrics side by side
Valuation
| Metric | INM | LGVN |
|---|---|---|
| P/S ratio | 0.00 | 6.13 |
| P/B ratio | 6.80 | 0.70 |
Profitability
| Metric | INM | LGVN |
|---|---|---|
| Gross margin | 14.92% | 69.76% |
| Operating margin | -0.52% | -1942.20% |
| Net margin | -0.61% | -1977.59% |
| ROE | -1168.44% | -225.67% |
| ROIC | -995.44% | -211.58% |
Growth (annualized)
| Metric | INM | LGVN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -21.21% |
| Total return CAGR (5Y) | -71.98% | -62.60% |
Frequently asked
- How have INM and LGVN total returns compared?
- Over the past 5 years, INM delivered -71.98% and LGVN delivered -62.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.